About BioMerieux
BioMerieux is a company founded in 1963.. The company has 14,750 employees as of December 31, 2024. BioMerieux has completed 15 acquisitions, including AES Chemunex, Advencis and Applied Maths. BioMerieux offers products and services including BIOFIRE, VIDAS, and VITEK. BioMerieux operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, CONMED and Johnson & Johnson, among others.
- Employees 14750 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biomerieux Sa
-
Annual Revenue
$4.13 B (USD)8.31as on Dec 31, 2024
-
Net Profit
$449.01 M (USD)20.86as on Dec 31, 2024
-
EBITDA
$928.05 M (USD)12.35as on Dec 31, 2024
-
Latest Funding Round
$243.86 K (USD), Grant
Nov 01, 2023
-
Investors
HHS
& 2 more
-
Employee Count
14750
as on Dec 31, 2024
-
Investments & Acquisitions
AES Chemunex
& 14 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioMerieux
BioMerieux is a publicly listed company on the EURONEXT with ticker symbol BIM in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioMerieux
BioMerieux offers a comprehensive portfolio of products and services, including BIOFIRE, VIDAS, and VITEK. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid system for molecular detection of infectious diseases
Automated platform for accurate immunoassay testing
Tool for microbial identification and susceptibility testing
Unlock access to complete
Unlock access to complete
Software Development Team
108 people
Leadership Team
86 people
Finance and Accounting
37 people
Human Resources and Administration
26 people
Product Management Team
21 people
Legal and Compliance
20 people
Senior Team
20 people
Global Team
18 people
Unlock access to complete
Funding Insights of BioMerieux
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $243,865
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Grant - BioMerieux | Valuation |
investors |
|
| May, 2021 | Amount | Grant - BioMerieux | Valuation |
investors |
|
| Jan, 2020 | Amount | Grant - BioMerieux | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioMerieux
BioMerieux has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, European Union and Sofina. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided by Sofina to emerging companies.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioMerieux
BioMerieux has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include AES Chemunex, Advencis and Applied Maths. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of culture media and microbiological products for laboratories
|
2015 | ||||
|
Solution for infection management and prescription management for hospitals and pharmacies
|
2012 | ||||
|
In-vitro diagnostic test cartridges are developed and manufactured via R&D.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - BioMerieux
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomerieux Comparisons
Competitors of BioMerieux
BioMerieux operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, CONMED and Johnson & Johnson, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Materials management solutions are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Wide range of medical devices
|
|
| domain | founded_year | HQ Location |
Surgical instruments are manufactured for multiple therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Healthcare solutions are provided by Johnson & Johnson globally.
|
|
| domain | founded_year | HQ Location |
Complex healthcare challenges are addressed through technology solutions by Commure.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomerieux
Frequently Asked Questions about BioMerieux
When was BioMerieux founded?
BioMerieux was founded in 1963 and raised its 1st funding round 46 years after it was founded.
Who is the current CEO of BioMerieux?
Alexandre Merieux is the current CEO of BioMerieux.
How many employees does BioMerieux have?
As of Dec 31, 2024, the latest employee count at BioMerieux is 14,750.
What is the annual revenue of BioMerieux?
Annual revenue of BioMerieux is $4.13B as on Dec 31, 2024.
What does BioMerieux do?
BioMérieux was established in 1963 within the diagnostics sector. Operations encompass the design, development, manufacture, and distribution of systems focused on in-vitro diagnostics for infectious diseases like hepatitis and HIV, alongside cardiovascular and cancer conditions. Industrial microbiological testing is also conducted for food, pharmaceutical, and environmental samples to assess quality. Annual revenues reached 3.6 billion in 2020, with net profits of 461 million recorded.
Who are the top competitors of BioMerieux?
BioMerieux's top competitors include GE Healthcare, Medtronic and Boston Scientific.
What products or services does BioMerieux offer?
BioMerieux offers BIOFIRE, VIDAS, and VITEK.
Is BioMerieux publicly traded?
Yes, BioMerieux is publicly traded on EURONEXT under the ticker symbol BIM.
How many acquisitions has BioMerieux made?
BioMerieux has made 15 acquisitions, including AES Chemunex, Advencis, and Applied Maths.
Who are BioMerieux's investors?
BioMerieux has 3 investors. Key investors include HHS, European Union, and Sofina.
What is BioMerieux's ticker symbol?
The ticker symbol of BioMerieux is BIM on EURONEXT.